What Naru Intelligence does

Naru Intelligence Solutions S.L. is a Spanish healthtech software company founded in 2016 and headquartered in Donostia-San Sebastián, operating with 11–50 employees. The company builds software and connected data infrastructure for clinical research, with two interlocking business lines: prospective ePRO (electronic Patient-Reported Outcomes) tools for clinical trials and observational studies, and retrospective Real-World Evidence (RWE) generation through a network of European hospitals. Its core products include Step PROMs (a real-time ePRO data collection platform), Step Oncology (a specialized oncology platform integrating patient monitoring, a prescription mobile app, evidence generation, and analytics), Step Proactive (a CE-marked patient monitoring medical device), and RWEvolution (a multi-center European program generating oncology RWE through a shared technology framework across partner hospitals).

The company targets three primary customer segments: pharmaceutical sponsors running clinical trials, Contract Research Organizations (CROs), and hospitals and oncology centers participating in the RWEvolution network. Revenue mechanics are subscription/recurring-based, delivered through a quote-based B2B sales model with no publicly disclosed pricing. Naru differentiates on data quality and adherence — reporting 96% patient adherence to ePRO questionnaires, 98% on-time completion, and 24 months of sustained adherence — alongside its CE-marked monitoring device and continuous data capture from the point of origin.

The business model relies on direct sales engagement and is regionally concentrated in Spain and broader Europe. Capital structure is private (Sociedad Limitada), supported by non-dilutive public funding including HAZITEK R&D grants (co-financed by Gobierno Vasco and FEDER 2021–2027), CDTI Innovación's Innvierte co-investment program, and ENISA innovation financing. No private venture funding rounds or revenue figures are disclosed in available sources.

Name

Naru Intelligence

Legal name

NARU INTELLIGENCE SOLUTIONS S.L.

Website

https://naruintelligence.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Naru Intelligence is a Spanish healthtech software company building ePRO and Real-World Evidence platforms for pharmaceutical sponsors, CROs, and European hospitals, with core offerings including Step PROMs, Step Oncology, Step Proactive (CE-marked), and the RWEvolution multi-center oncology network.

Ownership category

akta.pro rank

Headquarters

HQ city

Donostia-san Sebastián

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial ePRO Solutions: Services for clinical trials and prospective observational studies, helping sponsors and CROs optimize study execution, ensure quality and compliance, and generate evidence through innovative ePRO tools.
2. Retrospective RWE Studies: Solutions for retrospective observational studies that reduce time and costs in RWE generation through a unique high-quality data network.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Naru Intelligence develops and sells software solutions for clinical trials and real-world evidence (RWE) generation, with a specialization in oncology. Its core offering includes Step PROMs, an electronic Patient-Reported Outcomes (ePRO) platform that replaces paper-based data collection in clinical trials, and Step Oncology, a specialized oncology platform for structured clinical data capture combined with the RWEvolution European multi-center hospital network for continuous RWE generation. The portfolio also includes Step Proactive, a CE-marked certified patient monitoring medical device.

Product overview

Naru Intelligence offers a unified platform architecture centered on Real-World Evidence generation for clinical research and oncology. The portfolio consists of Step PROMs (ePRO solution for prospective clinical trials), Step Oncology (core platform for structured oncology data capture), and RWEvolution (European multi-center initiative connecting hospital networks for continuous RWE generation). Step Oncology integrates four sub-products: Step Proactive (CE-marked monitoring device), patient mobile app, evidence generation tools, and analytics dashboard. The products share a common technological infrastructure enabling structured data capture from origin, continuous PRO collection, and integrated analytics across clinical and real-world settings.

Differentiator

Problem solved

Functional benefit

Brands

• Step PROMs: An independent solution enabling real-time patient-reported outcomes collection in clinical trials, replacing paper-based processes to reduce study costs and generate richer, continuous insights.
• Step Oncology
• RWEvolution

Products and services

• Step PROMs

Quantifiable outcome

• 96% patient adherence to ePRO questionnaires
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

One partnership is on record.

• European Collaborating Hospitals (RWEvolution Network)coreStrategic or Co-development PartnerMulticentric European hospital network collaborating in the RWEvolution initiative for generating real-world oncology evidence. Hospitals use Step Oncology technology to capture structured data from origin without modifying clinical workflows.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• ObvioHealth: ObvioHealth is a digital health company offering ePRO and decentralized trial solutions, with comparable customer base (pharma sponsors and CROs) and overlapping product scope to Step PROMs.
• THREAD: THREAD provides a decentralized clinical trial platform with eCOA/ePRO capabilities, competing in the same emerging digital-PRO category as Naru but with a DCT-first orientation.
• Castor: Castor offers an eCRF and ePRO platform aimed at clinical trials, comparable in scale and target market to Naru, with a focus on accessible, modular clinical data capture.

Direct peers

• Veeva Systems: Veeva offers a clinical trial software suite including ePRO, EDC, and CTMS that competes with Naru's Step PROMs and broader clinical trial offerings for sponsor and CRO customers.
• Medidata (Dassault Systèmes): Medidata is the leading enterprise eCOA/ePRO platform used by most large pharmaceutical sponsors and CROs globally. It is a direct competitor to Step PROMs in clinical trial electronic patient-reported outcomes.
• Clario: Clario provides eCOA, imaging, and endpoint technology for clinical trials, including a dedicated ePRO solution that competes with Naru for sponsor and CRO contracts.
• Signant Health: Signant Health (formed from CRF Health and Bracket) is a specialist eCOA/ePRO provider focused on patient-centric clinical outcomes, directly comparable to Naru's Step PROMs offering.
• YPrime: YPrime is an eCOA and IRT specialist that offers ePRO solutions for clinical trials, comparable to Step PROMs in functionality and target customers.

Broad incumbents

• Flatiron Health: Flatiron Health (a Roche subsidiary) is a leading oncology-specific real-world evidence and EHR-data platform. It competes with Step Oncology and RWEvolution for oncology RWE generation.
• IQVIA: IQVIA is a global CRO and real-world evidence powerhouse that competes across the full stack — ePRO, RWE analytics, oncology evidence — that Naru serves, but at vastly greater scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/narusolutions

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Naru Intelligence